FDA clears Johnson & Johnson's Ottava robotic surgical system
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil prices set for weekly fall on easing fears over Saudi supply disruption
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
Johnson & Johnson Receives FDA Market Authorization in the U.S. for its OTTAVA™ Robotic Surgical System
July 22, 2026 7:00 AM EDTBuilt to open new possibilities in surgery, OTTAVA creates a new category in soft tissue robotics
System authorized for use in multiple procedures in general surgery within the upper abdomen
System features are designed to enable surgical teams and hospitals to expand OR capacity, streamline clinical workflows, and elevate surgical performance
NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for the OTTAVA Robotic Surgical System, the worlds first table-integrated soft... More
